Yunnan Botanee Bio-Technology Group Co.Ltd(300957) ( Yunnan Botanee Bio-Technology Group Co.Ltd(300957) ) disclosed the annual report of 2021 on March 22. During the reporting period, the company achieved an operating revenue of 4.022 billion yuan, an increase of about 52.57% year-on-year; The net profit attributable to the shareholders of the listed company was 863 million yuan, a year-on-year increase of about 58.77%; The basic earnings per share is 2.12 yuan. The company plans to distribute a cash dividend of 6.00 yuan (including tax) to all shareholders for every 10 shares.
On the same day, Yunnan Botanee Bio-Technology Group Co.Ltd(300957) released the 2021 social responsibility report and ESG (environment, society and Governance) report, which cut into the practice and effective actions of Yunnan Botanee Bio-Technology Group Co.Ltd(300957) in promoting the sustainable development of China's effective skin care in the three dimensions of environmental governance, social win-win and corporate governance through five modules of "standardized governance, scientific research and innovation, energy conservation and material conservation, employee orientation and public welfare".
According to the report, Yunnan Botanee Bio-Technology Group Co.Ltd(300957) is committed to enabling sustainable development through responsible management in 2021 Yunnan Botanee Bio-Technology Group Co.Ltd(300957) initially set up the ESG control structure, under the guidance of the strategy committee under the board of directors, under the leadership of the Secretary of the board of directors and the office of the Secretary of the board of directors to undertake the overall planning work related to the implementation of ESG.
In December 2021, Yunnan Botanee Bio-Technology Group Co.Ltd(300957) which has been listed for less than one year was included in the list of constituent stocks of Shenzhen composite index, gem index and Shenzhen 100 (collectively referred to as "1 + 2" core index). By the end of 2021, Yunnan Botanee Bio-Technology Group Co.Ltd(300957) R & D team had gathered 236 people, accounting for 10% of the company's total employees; Realize the accumulation of 80 patents; Clinical research and effect observation of dermatology in 63 hospitals; Participate in the formulation of 20 group standards for efficacy skin care products in China; Revise 15 national expert guides and consensus; Preside over the formulation of 11 enterprise product standards; The products have been included in 154 SCI and core journal papers.
At the end of December 2021, Yunnan Botanee Bio-Technology Group Co.Ltd(300957) led the establishment of Yunke characteristic plant extraction laboratory, gathered the scientific research strength of Yunnan Pharmaceutical Research Institute, Yunnan University and Yunnan Agricultural University, and built a public platform for research and development of Yunnan characteristic plant industry. Focus on the research and development of functional cosmetics, functional foods and drugs with Yunnan characteristic plant extracts as raw materials, and develop characteristic plant health products with high added value. At the same time, Yunnan Botanee Bio-Technology Group Co.Ltd(300957) reduces VOC emissions by optimizing the size of packaging materials, improving the manufacturing process, optimizing the properties of packaging materials, such as SFC international forest paper, and replacing oily ink, such as water-based ink and soybean ink.
In 2021, Yunnan Botanee Bio-Technology Group Co.Ltd(300957) devoted himself to ecological protection projects. Jointly set up Yunnan Botanee Bio-Technology Group Co.Ltd(300957) public welfare fund with Yunnan Youth Foundation, which is the first special public welfare fund of Yunnan hope project focusing on ecological and environmental protection public welfare undertakings such as "biodiversity protection" of teenagers.
The report mentioned that Yunnan Botanee Bio-Technology Group Co.Ltd(300957) continued to invest 16.66 million yuan in public welfare undertakings in 2021, supported 12 public welfare projects, and the cumulative number of beneficiaries reached 190000.
